Sharechat Logo

Mondrian Investment sells down holding in F&P Healthcare

Tuesday 31st January 2012

Text too small?

Mondrian Investment Partners, a fund manager whose mandates include a share of the UK's Pension Protection Fund, sold down its stake in Fisher & Paykel Healthcare in the biggest transaction in the stock for 15 months.

The fund manager based in London and Philadelphia sold 7.66 million shares, or about 1.4 percent of F&P Healthcare, reducing its holding to 4.1 percent from 6.08 percent, it said in a notice to the NZX.

Shares of the company have shed about a third of their value in the past 12 months and closed yesterday at $2.18, down from $3.18 a year ago. The stock is rated ‘outperform’ based on the consensus of nine analysts polled by Reuters with a price target of $2.75.

Mondrian has some US$65 billion under management, according to its website. Of that, 45 percent is invested in equities in developed markets.


  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar rally may limit profit gains for Fisher and Paykel Healthcare, brokerage says
Shares in Fisher and Paykel Healthcare third-best performer on NZX 50 after raising earnings forecast
Fisher and Paykel Healthcare raises 2014 earnings forecast on higher sales, margins
F and P Healthcare shares jump to highest in more than 2 years on profit outlook
F and P Healthcare beats 2013 guidance, forecasts boost in 2014 profit; shares gain to 2 1/2 year high
F and P Healthcare shares rise to two-year high as First NZ raises rating on better outlook
Fisher & Paykel Healthcare
F and P Healthcare lifts guidance as sales grow, margins widen; shares rally
F&P Healthcare 1H profit rises 18%, on record sales, wider margins